Adjuvant treatment with tamoxifen substantially improves survival of women with estrogen-receptor positive (ER+) tumors. Tamoxifen resistance (TAMR) limits clinical benefit. RRR alpha tocopherol ether-linked acetic acid analogue (alpha-TEA) is a small bioactive lipid with potent anticancer activity. We evaluated the ability of alpha-TEA in the presence of tamoxifen to circumvent TAMR in human breast cancer cell lines. Methods: Two genotypically matched sets of TAM-sensitive (TAMS) and TAM-resistant (TAMR) human breast cancer cell lines were assessed for signal-transduction events with Western blotting, apoptosis induction with Annexin V-FITC/PI assays, and characterization of cholesterol-rich microdomains with fluorescence staining. Critica...
Breast cancer is the most common cancer and the leading cause of cancer death in women. Although tam...
Breast cancer is the most common cancer and the leading cause of cancer death in women. Although tam...
Tamoxifen (TAM) has both cytostatic and cytotoxic properties for breast cancer. TAM engaged mitochon...
Adjuvant treatment with tamoxifen substantially improves survival of women with estrogen-receptor po...
1 School of Biological Sciences/A5000, University of Texas at Austin, 1 University Station, Austin, ...
textBreast cancer is the second leading cause of mortality among women in the US. A contributing fac...
Background: Tamoxifen treatment of estrogen receptor (ER)-positive breast cancer reduces mortality b...
International audienceBreast cancer (BC) is one of the most common female cancers in the world, with...
Tamoxifen is the most widely used adjuvant chemotherapeutic for the treatment of estrogen receptor (...
International audienceTamoxifen (Tam) is a selective estrogen receptor modulator (SERM) that remains...
Tamoxifen is the most widely used adjuvant chemotherapeutic for the treatment of estrogen receptor (...
Breast cancer is the most common type of cancer in women worldwide. Approximately two-thirds of brea...
textSecond only to lung cancer, breast is the leading type of cancer among women in the US. Despite...
International audienceThe microsomal antiestrogen-binding site (AEBS) is a high-affinity membranous ...
Breast cancer is the most common cancer and the leading cause of cancer death in women. Although tam...
Breast cancer is the most common cancer and the leading cause of cancer death in women. Although tam...
Tamoxifen (TAM) has both cytostatic and cytotoxic properties for breast cancer. TAM engaged mitochon...
Adjuvant treatment with tamoxifen substantially improves survival of women with estrogen-receptor po...
1 School of Biological Sciences/A5000, University of Texas at Austin, 1 University Station, Austin, ...
textBreast cancer is the second leading cause of mortality among women in the US. A contributing fac...
Background: Tamoxifen treatment of estrogen receptor (ER)-positive breast cancer reduces mortality b...
International audienceBreast cancer (BC) is one of the most common female cancers in the world, with...
Tamoxifen is the most widely used adjuvant chemotherapeutic for the treatment of estrogen receptor (...
International audienceTamoxifen (Tam) is a selective estrogen receptor modulator (SERM) that remains...
Tamoxifen is the most widely used adjuvant chemotherapeutic for the treatment of estrogen receptor (...
Breast cancer is the most common type of cancer in women worldwide. Approximately two-thirds of brea...
textSecond only to lung cancer, breast is the leading type of cancer among women in the US. Despite...
International audienceThe microsomal antiestrogen-binding site (AEBS) is a high-affinity membranous ...
Breast cancer is the most common cancer and the leading cause of cancer death in women. Although tam...
Breast cancer is the most common cancer and the leading cause of cancer death in women. Although tam...
Tamoxifen (TAM) has both cytostatic and cytotoxic properties for breast cancer. TAM engaged mitochon...